title: Inactivation of chicken mitochondrial phosphoenolpyruvate carboxykinase by o-phthalaldehyde.
abstract: Chicken liver mitochondrial phosphoenolpyruvate carboxykinase is inactivated by o-phthalaldehyde. The inactivation followed pseudo first-order kinetics, and the second-order rate constant for the inactivation process was 29 M-1 s-1 at pH 7.5 and 25 degrees C. The modified enzyme showed maximal fluorescence at 427 nm upon excitation at 337 nm, consistent with the formation of isoindole derivatives by the cross-linking of proximal cysteine and lysine residues. Activities in the physiologic reaction and in the oxaloacetate decarboxylase reaction were lost in parallel upon modification with o-phthalaldehyde. Plots of (percent of residual activity) versus (mol of isoindole incorporated/mol of enzyme) were biphasic, with the initial loss of enzymatic activity corresponding to the incorporation of one isoindole derivative/enzyme molecule. Complete inactivation of the enzyme was accompanied by the incorporation of 3 mol of isoindole/mol of enzyme. beta-Sulfopyruvate, an isoelectronic analogue of oxaloacetate, completely protected the enzyme from reacting with o-phthalaldehyde. Other substrates provided protection from inactivation, in decreasing order of protection: oxaloacetate greater than phosphoenolpyruvate greater than MgGDP, MgGTP greater than oxalate. Cysteine 31 and lysine 39 have been identified as the rapidly reacting pair in isoindole formation and enzyme inactivation. Lysine 56 and cysteine 60 are also involved in isoindole formation in the completely inactivated enzyme. These reactive cysteine residues do not correspond to the reactive cysteine residue identified in previous iodoacetate labeling studies with the chicken mitochondrial enzyme (Makinen, A. L., and Nowak, T. (1989) J. Biol. Chem. 264, 12148-12157). Protection experiments suggest that the sites of o-phthalaldehyde modification become inaccessible when the oxaloacetate/phosphoenolpyruvate binding site is saturated, and sequence analyses indicate that cysteine 31 is located in the putative phosphoenolpyruvate binding site.
authors.affiliation: Department of Biochemistry, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.
authors.forename: C Y
authors.initials: CY
authors.lastname: Chen
authors.forename: F A
authors.initials: FA
authors.lastname: Emig
authors.forename: V L
authors.initials: VL
authors.lastname: Schramm
authors.forename: D E
authors.initials: DE
authors.lastname: Ash
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002645:Chickens; D002851:Chromatography, High Pressure Liquid; D003545:Cysteine / Q000737:chemistry / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007211:Indoles / Q000737:chemistry; D007461:Iodoacetates / Q000494:pharmacology; D019807:Iodoacetic Acid; D008928:Mitochondria / Q000201:enzymology*; D008969:Molecular Sequence Data; D010449:Peptide Mapping; D010729:Phosphoenolpyruvate Carboxykinase (GTP) / Q000037:antagonists & inhibitors* / Q000378:metabolism; D016415:Sequence Alignment; D013050:Spectrometry, Fluorescence; D013379:Substrate Specificity; D009764:o-Phthalaldehyde / Q000494:pharmacology*
chemical_list: D007211:Indoles; D007461:Iodoacetates; D009764:o-Phthalaldehyde; D010729:Phosphoenolpyruvate Carboxykinase (GTP); D003545:Cysteine; D019807:Iodoacetic Acid